Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
BeOne Medicines
Welcome,
Profile
Billing
Logout
30 Products
605 Diseases
30 Products
1523 Trials
32513 News
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
92
184
276
368
460
552
644
736
828
920
Tevimbra
(tislelizumab-jsgr) / BeiGene
Prolia
(denosumab) / Amgen
Mekinist
(trametinib) / Novartis, BeiGene
pazopanib
/ Generic mfg.
Brukinsa
(zanubrutinib) / BeiGene
Tafinlar
(dabrafenib) / Novartis
Blincyto
(blinatumomab) / Astellas, Amgen
Lumakras
(sotorasib) / Amgen
Zykadia
(ceritinib) / Novartis
Sylvant
(siltuximab) / Jazz
Avzivi
(bevacizumab-tnjn) / Bio-Thera Solutions, Cipla, BeiGene, Biomm, Mega Lifesciences, Sandoz
Partruvix
(pamiparib) / BeiGene
sitravatinib
(MGCD516) / BeiGene
Qarziba
(dinutuximab beta) / Jazz
sonrotoclax
(BGB-11417) / BeiGene
Gomekli
(mirdametinib) / SpringWorks Therap
Imdelltra
(tarlatamab-dlle) / Amgen
Ziihera
(zanidatamab-hrii) / Jazz
sirexatamab
(DKN-01) / Leap Therap
ociperlimab
(BGB-A1217) / BeiGene
Baituowei
(goserelin acetate sustained-release microspheres for injection) / Luye Group
vebicorvir
(ABI-H0731) / Assembly Biosci
alcestobart
(LBL-007) / BeiGene
catadegbrutinib
(BGB-16673) / BeOne Medicines
ABI-H2158
/ Assembly Biosci
BGB-A445
/ BeiGene
BGB-15025
/ BeiGene
DXP-604
/ BeiGene
lifirafenib
(BGB-283) / BeiGene
xaluritamig
(AMG 509) / Amgen
DXP-593
/ BeiGene
acapatamab
(AMG 160) / Amgen, BeiGene
brimarefenib
(BGB-3245) / MapKure, SpringWorks Therap
pavurutamab
(AMG 701) / Amgen
surzebiclimab
(BGB-A425) / BeiGene
tapotoclax
(AMG 176) / Amgen
ABI-H3733
/ Assembly Biosci, BeiGene
BGB-23339
/ BeiGene
BGB-B167
/ BeiGene
IGM-6268
/ Atreca, BeiGene, IGM Biosciences
evalstotug
(BA3071) / BeiGene
garivulimab
(BGB-A333) / BeiGene
sovilnesib
(AMG 650) / Volastra Therap
zanidatamab zovodotin
(ZW49) / Zymeworks
BGB-10188
/ BeiGene
BGB-108
/ BeiGene
BGB-24714
/ BeiGene
BITR2101
/ Boston Immune Tech
MP0310
/ Molecular Partners
PF-08046040
/ Pfizer
1
2
»
